4 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of V540A in Healthy Female Participants (V540A-005) V540A-2, V540A-3, GARDASIL®9 - Healthy | Phase 2 | Withdrawn | Merck Sharp & Dohme LLC | 2026-07-20 | 2026-09-14 | |
| Assessing the Safety of an IGY Supplement on the Gut Microbiome IgY supplement, Placebo - Healthy, Microbiome | Phase 1 / Phase 2 | Withdrawn | Nimble Science Ltd. | 2026-01-01 | 2026-09-30 | |
| rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers yohimbine + hydrocortisone, medial prefrontal cortex rTMS, Placebo oral tablet - Stress, Healthy | Phase 2 | Withdrawn | Wayne State University | 2023-04-10 | 2023-04-13 | |
| A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Participants Placebo, JNJ-64281802 High dose, JNJ-64281802 Medium dose - Healthy | Phase 2 | Withdrawn | Janssen Research & Development, LLC | 2020-07-28 | 2025-01-10 |
Hydrocortisone (1) · Neu1 protein, mouse (1) · Yohimbine (1)
Janssen Research & Development, LLC (1) · Merck Sharp & Dohme LLC (1) · Nimble Science Ltd. (1) · Wayne State University (1)
Canada (1) · United States (1)